Diversified Enterprises’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Diversified Enterprises's VRTX Position: Q2 2026 in Review
Diversified Enterprises reduced its Vertex Pharmaceuticals (VRTX) stake by 39% in Q2 2026, selling an estimated $248K and leaving 873 shares worth $434K. The position accounts for 0.02% of the portfolio, ranked #267.
Diversified Enterprises first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $729K in Q4 2025. 1,759 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Diversified Enterprises held 873 shares of Vertex Pharmaceuticals worth $434K as of Q2 2026.
- Diversified Enterprises sold 559 Vertex Pharmaceuticals shares in Q2 2026, an estimated $248K.
- Vertex Pharmaceuticals made up 0.02% of Diversified Enterprises's portfolio in Q2 2026, its #267 holding.
- Diversified Enterprises first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- Diversified Enterprises's Vertex Pharmaceuticals position peaked at $729K in Q4 2025.
- 1,759 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.